Epalrestat-M Tablet

Product Description

USES :

This is a combination of two medicines: Epalrestat and methylcobalamin which treat diabetic nerve disease. Epalrestat is an aldose reductase inhibitor. It blocks the accumulation of sorbitol in cells which has been related in causing diabetic nerve disease. Methylcobalamin is a form of vitamin B which helps in the production of myelin a substance that protects nerve fibers and rejuvenates damaged nerve cells.

SIDE EFFECTS :

Nausea Vomiting Increased liver enzymes.

Comprehensive Management of Diabetic Neuropathy

Epalrestat-M Tablet offers dual-action relief for diabetic patients by combining Epalrestat and Metformin. Epalrestat addresses nerve damage by inhibiting aldose reductase, while Metformin helps regulate blood glucose levels. This synergy delivers noticeable benefits in controlling diabetes-related complications and offers better glycemic and neurological outcomes for adult patients.


Quality Assurance & High Purity Composition

Formulated with active pharmaceutical ingredients of 99% purity, Epalrestat-M upholds stringent quality standards for safety and efficacy. The unique combination ensures precise, consistent dosing with every tablet, validated by a comprehensive assay. Its film-coated design improves tolerability and patient compliance.


Practical Dosage and User Convenience

Epalrestat-M is available in easily manageable blister packs, designed for simple dispensing by healthcare professionals or distributors. Tablets should be taken exactly as prescribed by a physician. Clear storage guidelines are provided to preserve efficacy, ensuring a reliable 24-month shelf life when stored properly.